Mireculeincis A Biotechnology Company Located In Gaithersburgmarylandfounded In 2018The Company Specializes In Developing Rna Therapies Aimed At Treating Cancer And Muscular Dystrophyutilizing Its Proprietary Dreamir Platformthis Platform Analyzes Genomic And Outcome Data From Numerous Patients To Identify Genetic Changes That Lead To Diseasesfacilitating The Creation Of Targeted Rna Therapeutics The Company Focuses On Personalized Rna Based Therapiesensuring That Treatments Are Tailored To Individual Patient Needsmirecule S Lead Programs Include Therapies For Head And Neck Squamous Cell Carcinomahnsccand Facioscapulohumeral Muscular Dystrophyfshd Notablythe Company Has Partnered With Sanofi To Develop An Antibody Rna Conjugate For Fshdmarking A Significant Step In Its Licensing Efforts With A Revenue Of Approximately $5 Million And A Dedicated Teammirecule Operates Within The Biotechnology Sectoremphasizing Precision Medicine And Innovative Therapies For Rare Diseases
